Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CanaQuest Medical Corp CANQF

CanaQuest Medical Corp is a Canada-based clinical-stage, life sciences company. The Company is focused on the drug discovery and development of targeted therapeutics within the endocannabinoidome, including PPAR receptors. The Company is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and post-traumatic stress disorder (PTSD). It has created a natural formulation derived from cannabidiol + proprietary API composition. The Company has a drug candidate, CQ-001, positioned for clinical trials targeting epilepsy. Its CQ-001 drug candidate combines cannabidiol (CBD) with essential fatty acids (Omega-3s). In addition, the Company is also focused on developing a nutraceutical version of the formulation, Mentanine, which is scheduled for clinical studies to investigate its potential applications across various indications, paving the way for future clinical trials.


OTCPK:CANQF - Post by User

Post by averagepennieson Oct 31, 2023 9:42am
60 Views
Post# 35708981

NHL Alumni Association partners with CanaQuest and NEEKA

NHL Alumni Association partners with CanaQuest and NEEKATORONTO, ON / ACCESSWIRE / October 31, 2023 / NHL Alumni Association (NHLAA), NEEKA Health Canada("NEEKA"),and CanaQuest Medical Corp ("CanaQuest") are pleased to announce a transformative study partnership that will investigate the efficacy of Mentanine® as a potential treatment to reduce anxiety in former NHL players.

https://www.accesswire.com/797863/nhl-alumni-association-partners-with-canaquest-and-neeka-health-to-conduct-studies-for-anxiety-and-quality-of-life-in-former-nhl-players
<< Previous
Bullboard Posts
Next >>